The global clinical trials matching software market was valued at USD 210.7 million in 2025 and is expected to reach USD 237.9 million in 2026. The market is projected to expand to USD 595.3 million by 2033, registering a 14.0% CAGR from 2026 to 2033.

The market is being driven by the increasing complexity of clinical trials, growing adoption of artificial intelligence (AI) and machine learning (ML) for patient recruitment, and the need for sponsors and research organizations to improve enrollment efficiency. As clinical studies involve increasingly specialized patient populations and more complicated eligibility requirements, software capable of rapidly identifying suitable participants is becoming increasingly important.

Market Performance at a Glance

• 2025 market size: USD 210.7 million
• 2026 estimated market size: USD 237.9 million
• 2033 projected market size: USD 595.3 million
• 2026–2033 CAGR: 14.0%
• Leading region: North America
• North America revenue share in 2025: 50.1%
• Fastest-growing region: Asia Pacific
• Largest country market: U.S.

What Is Driving Market Expansion?

Clinical trial design has become increasingly sophisticated as pharmaceutical and biotechnology companies investigate a broader range of disease subtypes, targeted therapies, and specialized patient populations. These developments have created more complex eligibility criteria and made identifying appropriate participants increasingly difficult.

According to insights from myTomorrows published in February 2025, more than 500,000 clinical trials are registered globally, while more than 8,000 drugs are in development. This expanding clinical research landscape creates substantial challenges for physicians, sponsors, and clinical research sites seeking appropriate trial candidates.

Limited trial visibility can further complicate recruitment and retention. Pharmaceutical and biotechnology companies are therefore adopting advanced clinical trial matching solutions to identify eligible participants faster, accelerate enrollment, lower recruitment-related costs, and improve the likelihood of trial success.

Download a free sample report or claim your copy of this full market intelligence report

Recruitment Efficiency Is Becoming a Critical Priority

Patient recruitment remains one of the major operational challenges in clinical research. Statistics published by Antidote Technologies, Inc. in January 2024 indicate that approximately 80% of clinical trials fail to meet their enrollment timelines.

As trials become more complex, conventional recruitment approaches may struggle to process the large volumes of patient information required for accurate eligibility assessment. Clinical trials matching software can analyze large datasets and compare patient characteristics against complex eligibility requirements, helping research teams identify potentially suitable participants more efficiently.

By shortening the time required to locate and screen candidates, these platforms can help reduce delays and the costs associated with prolonged clinical trial timelines.

AI and Machine Learning Are Transforming Patient Matching

Artificial intelligence, machine learning, and big data analytics are becoming important technologies within clinical trial recruitment and management. AI-enabled solutions can process information from electronic health records (EHRs) and other healthcare data sources to identify patients who may meet specific trial criteria.

The integration of these technologies can improve matching accuracy, automate eligibility assessment, reduce manual workload, and support more efficient recruitment processes.

A notable development occurred in February 2025, when myTomorrows launched a next-generation AI platform designed to improve clinical trial recruitment. The platform enables physicians to search, pre-screen, and refer patients through an integrated system, helping trial sponsors accelerate enrollment, improve participant diversity, and optimize trial operations.

The platform's AI-powered pre-screening functionality reportedly automates eligibility checks with 98% accuracy, demonstrating the potential for AI to reduce the manual burden associated with patient-trial matching.

Regulatory Pressure Supports Adoption

Regulatory authorities worldwide continue to emphasize faster drug development and more efficient clinical research processes. Programs such as the U.S. FDA's Breakthrough Therapy Designation are intended to accelerate development and review for certain promising therapies.

As sponsors face increasing pressure to deliver trials efficiently while meeting regulatory expectations, effective recruitment and trial-matching technologies can become an important component of clinical development strategies. Software that helps identify eligible patients quickly may support more timely enrollment and contribute to streamlined trial execution.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Segment and Regional Landscape

Web & Cloud Deployment Leads

The web & cloud segment represented the largest share of the clinical trials matching software market, accounting for 92.8% of revenue in 2025. Cloud-based deployment can support centralized access to clinical trial and patient information, making it suitable for organizations operating across multiple research sites and locations.

Pharmaceutical & Biotechnology Companies Represent the Largest End-use Segment

The pharmaceutical & biotechnology companies segment accounted for the largest revenue share, at 43.2% in 2025. These organizations have a strong need to identify suitable trial participants efficiently as clinical development programs become more specialized and involve increasingly complex eligibility criteria.

North America Maintains Market Leadership

North America dominated the global market in 2025, accounting for 50.1% of revenue. The region's leading position is supported by its established clinical research infrastructure, substantial pharmaceutical and biotechnology sector, and adoption of advanced healthcare technologies.

The U.S. held the largest country-level market share in 2025.

Meanwhile, Asia Pacific is expected to record the fastest CAGR from 2026 to 2033, indicating increasing adoption and expanding opportunities for clinical trial matching technologies across the region.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Competitive Landscape

The clinical trials matching software market includes technology providers, healthcare technology companies, clinical research technology firms, and organizations developing AI-enabled patient recruitment solutions.

Key companies profiled in the study include:

• IBM
• Antidote Technologies, Inc.
• Ofni Systems
• Clario
• Advarra
• ArisGlobal
• BSI Business Systems Integration AG
• Teckro Limited
• Evidation Health, Inc.
• HealthMatch
• Microsoft
• Deep6.ai
• Inspirata, Inc.

Explore our dedicated business services:

Prism AI: Market Intelligence with Cited Research- Ask questions in plain language and get insights drawn from Grand View Research's entire research library, with sources cited. Create your free account today.

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today